×
Back to Agenda
Session 7: Case Study of an ATMP Launch in Europe
Session Chair(s)
Alexander Natz, JD
Secretary General, European Confederation of Pharmaceutical Entrepreneurs, Belgium
? Legal challenges ? Reimbursement challenges ? Differences between tissue engineering & cell and gene therapies ? What are first launch countries in the EU for ATMPs? ? Logistical challenges for ATMPs ? Linking registries with innovative payment models ? How to approach payers at the right point in time? ? The need for cross-border healthcare
Speaker(s)
Leo Strican
Head of Access Value & Evidence Strategy, Bluebird Bio, United States
Case Study from Bluebird Bio
Have an account?